CORE--Biostatistics
核心--生物统计学
基本信息
- 批准号:7786063
- 负责人:
- 金额:$ 55.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-15 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllopurinolAnimalsAreaBackBiologicalBiological AssayBiometryBiostatistics CoreCardiacCharacteristicsClassificationComputer softwareDataData CollectionData QualityData SecurityData SetDatabasesDevelopmentDiseaseDocumentationEnrollmentEnsureEnvironmentFacultyFunctional disorderGoalsHeadImageInformation SystemsLeadManuscriptsMethodologyMethodsPatientsPreparationPrimary HyperaldosteronismQuality ControlReportingResearch DesignSecureSecurity MeasuresStructureSystemTestingTimeTrainingWorkWorkloadbasecomputerized data processingdata managementdesigndistributed dataexperienceinflammatory markermeetingsprograms
项目摘要
Biostatistics is responsible for support with respect to data management and analysis of results. With regard to data management, we will be responsible for creating an "environment", and for providing training that will ensure that data are collected and managed using methods that result in a high-quality database. The basis of the approach is the now widely accepted "distributed data management" approach where the staff manage the data arising from their activities using systems created by Biostatics. This approach has been shown to result in higher-quality data, and not result in an increased workload. The data management "environment" is created by meeting responsibilities that include the creation of documentation, training materials, study databases, and archival structures for the processing of data. In addition, we will work with project and core staff to ensure that they are appropriately training in the use of these systems. Finally, Biostatistics will be responsible for providing secure backup and security measures for efforts. Biostatistics will also work with the project in the analysis and reporting of study
results. The faculty has worked closely with the project faculty in the development of
approaches that appropriately address hypotheses. Biostatistics will be responsible for performing the appropriate analyses, working with the staff in the interpretation of results, participating in the development of manuscripts and other reports summarizing the results.
生物统计学负责数据管理和结果分析方面的支持。在数据管理方面,我们将负责创造一个“环境”,并提供培训,以确保使用能够产生高质量数据库的方法收集和管理数据。该方法的基础是现在被广泛接受的“分布式数据管理”方法,工作人员使用Biostatics创建的系统管理其活动产生的数据。事实证明,这种方法可以产生更高质量的数据,而不会增加工作负载。数据管理“环境”是通过满足职责而创建的,这些职责包括创建文档、培训材料、研究数据库和数据处理的档案结构。此外,我们将与项目和核心工作人员合作,确保他们在使用这些系统方面得到适当的培训。最后,生物统计学将负责为工作提供安全备份和安全措施。生物统计学也将与项目一起分析和报告研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Howard其他文献
George Howard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Howard', 18)}}的其他基金
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10688017 - 财政年份:2021
- 资助金额:
$ 55.89万 - 项目类别:
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10294280 - 财政年份:2021
- 资助金额:
$ 55.89万 - 项目类别:
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10473895 - 财政年份:2021
- 资助金额:
$ 55.89万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
10298040 - 财政年份:2014
- 资助金额:
$ 55.89万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
8577740 - 财政年份:2014
- 资助金额:
$ 55.89万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
9898483 - 财政年份:2014
- 资助金额:
$ 55.89万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
8099667 - 财政年份:2010
- 资助金额:
$ 55.89万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
7848501 - 财政年份:2010
- 资助金额:
$ 55.89万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
8282865 - 财政年份:2010
- 资助金额:
$ 55.89万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
8479444 - 财政年份:2010
- 资助金额:
$ 55.89万 - 项目类别:
相似国自然基金
Apocynin和allopurinol对运动上调自发性高血压大鼠肾脏一氧化氮合成酶表达的影响
- 批准号:81301667
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
- 批准号:
10701217 - 财政年份:2023
- 资助金额:
$ 55.89万 - 项目类别:
Association Between Allopurinol and Cardiovascular Events, Mortality and End-Stage Renal Disease in Diabetes
别嘌呤醇与糖尿病心血管事件、死亡率和终末期肾病之间的关联
- 批准号:
377029 - 财政年份:2017
- 资助金额:
$ 55.89万 - 项目类别:
Fellowship Programs
CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression
CKD-FIX:别嘌呤醇减缓肾脏疾病进展的随机对照试验
- 批准号:
nhmrc : GNT1043203 - 财政年份:2013
- 资助金额:
$ 55.89万 - 项目类别:
Project Grants
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
9738022 - 财政年份:2013
- 资助金额:
$ 55.89万 - 项目类别:
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
8644403 - 财政年份:2013
- 资助金额:
$ 55.89万 - 项目类别:
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验
- 批准号:
8445008 - 财政年份:2012
- 资助金额:
$ 55.89万 - 项目类别:
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验设计
- 批准号:
8250159 - 财政年份:2011
- 资助金额:
$ 55.89万 - 项目类别:
Analysis of the mechanisms of allopurinol-induced severe cutaneous adverse reactions
别嘌呤醇致严重皮肤不良反应的机制分析
- 批准号:
23790611 - 财政年份:2011
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ALLOPURINOL AND CARDIAC FUNCTION IN IDIOPATHIC DILATED CARDIOMYOPATHY
特发性扩张型心肌病中别嘌呤醇与心脏功能
- 批准号:
7199117 - 财政年份:2004
- 资助金额:
$ 55.89万 - 项目类别:
ALLOPURINOL AND THE PREVENTION OF DEATH, TISSUE INJURY, AND SEIZURES IN CHD
别嘌呤醇与预防冠心病死亡、组织损伤和癫痫发作
- 批准号:
6116864 - 财政年份:1998
- 资助金额:
$ 55.89万 - 项目类别: